Phenanthriplatin, a Monofunctional DNA-binding Platinum Anticancer Drug Candidate With Unusual Potency and Cellular Activity Profile

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1207670109
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Cellular Recognition and Repair of Monofunctional–Intercalative Platinum–DNA Adducts

Chemical Research in Toxicology
MedicineToxicology
2015English

A New Platinum(II) Compound Anticancer Drug Candidate With Selective Cytotoxicity for Breast Cancer Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2014English

DNA-Binding and Anticancer Activity of Pyrene-Imidazolium Derivatives

ChemistrySelect
Chemistry
2016English

Quantifying Anticancer Drug Doxorubicin Binding to DNA Using Optical Tweezers

Biophysical Journal
Biophysics
2019English

Platinum Intercalators of DNA as Anticancer Agents

European Journal of Inorganic Chemistry
Inorganic Chemistry
2017English

Glyconanoparticles for Targeted Tumor Therapy of Platinum Anticancer Drug

English

Binding Profile of SM-9018, a Novel Antipsychotic Candidate.

The Japanese Journal of Pharmacology
1990English

Identification of a Phenanthrene Derivative as a Potent Anticancer Drug With Pim Kinase Inhibitory Activity

Cancer Science
Cancer ResearchMedicineOncology
2011English

Mechanism of the Membrane Interaction of Polynuclear Platinum Anticancer Agents. Implications for Cellular Uptake

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy